Hahn Capital Management LLC Acquires 18,067 Shares of Agilent Technologies, Inc. (NYSE:A)

Hahn Capital Management LLC raised its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 33.5% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 71,951 shares of the medical research company’s stock after buying an additional 18,067 shares during the quarter. Agilent Technologies comprises approximately 4.4% of Hahn Capital Management LLC’s holdings, making the stock its 7th largest holding. Hahn Capital Management LLC’s holdings in Agilent Technologies were worth $9,327,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Crewe Advisors LLC boosted its position in Agilent Technologies by 114.8% in the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after purchasing an additional 101 shares in the last quarter. Livelsberger Financial Advisory acquired a new position in shares of Agilent Technologies in the 4th quarter valued at $26,000. VisionPoint Advisory Group LLC purchased a new stake in Agilent Technologies during the fourth quarter worth $29,000. Ridgewood Investments LLC acquired a new stake in Agilent Technologies during the second quarter valued at $29,000. Finally, Rise Advisors LLC raised its holdings in Agilent Technologies by 527.8% in the 1st quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock worth $33,000 after purchasing an additional 190 shares during the period. 87.42% of the stock is currently owned by institutional investors and hedge funds.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $137.20 on Friday. The business’s 50 day moving average price is $135.62 and its 200 day moving average price is $139.06. The company has a market cap of $40.03 billion, a price-to-earnings ratio of 32.43, a PEG ratio of 6.63 and a beta of 1.05. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78. Agilent Technologies, Inc. has a one year low of $96.80 and a one year high of $155.35.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, August 21st. The medical research company reported $1.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.06. The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.56 billion. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. Agilent Technologies’s quarterly revenue was down 5.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.43 earnings per share. On average, research analysts predict that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Insider Buying and Selling at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the sale, the chief executive officer now directly owns 24,118 shares of the company’s stock, valued at approximately $3,497,110. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, SVP Dominique Grau sold 15,000 shares of the firm’s stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $133.28, for a total value of $1,999,200.00. Following the completion of the transaction, the senior vice president now owns 49,486 shares of the company’s stock, valued at $6,595,494.08. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total transaction of $283,910.00. Following the completion of the transaction, the chief executive officer now directly owns 24,118 shares of the company’s stock, valued at approximately $3,497,110. The disclosure for this sale can be found here. Insiders have sold 18,916 shares of company stock worth $2,557,230 over the last quarter. 0.33% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Evercore ISI boosted their price objective on Agilent Technologies from $130.00 to $135.00 and gave the company an “in-line” rating in a research report on Thursday, August 22nd. Wolfe Research cut shares of Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research report on Thursday, June 27th. TD Cowen lifted their target price on shares of Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a research report on Thursday, August 22nd. Citigroup boosted their target price on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Finally, UBS Group raised their price target on shares of Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a research note on Thursday, August 22nd. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $141.60.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.